Patent assignee · US · COMPANY

Stembios Technologies, Inc.

13Patents
13Active
13Granted
46Portfolio score

Filing activity: Jan 13, 2010 → Aug 7, 2019 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8394630B2 Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs) Physics 6 Active
US8623642B2 Somatic stem cells Chemistry; Metallurgy 4 Active
US8986679B2 Somatic stem cells Chemistry; Metallurgy 0 Active
US10143710B2 Somatic stem cells Chemistry; Metallurgy 0 Active
US9777259B2 Somatic stem cells Chemistry; Metallurgy 0 Active
US9810684B2 Method for increasing number of stem cells in human or animal bodies Physics 0 Active
US9072719B2 Somatic stem cells Chemistry; Metallurgy 0 Active
US8679474B2 Somatic stem cells Chemistry; Metallurgy 0 Active
US9770473B2 Treatment of immunosuppression-related disorders Chemistry; Metallurgy 0 Active
US9155763B2 Lgr5+ somatic stem cells Chemistry; Metallurgy 0 Active
US11492592B2 Lgr5+ somatic stem cells Chemistry; Metallurgy 0 Active
US9856452B2 Lgr5+ somatic stem cells Chemistry; Metallurgy 0 Active
US9415073B2 Somatic stem cells Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.